Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
CACASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASI)

NASDAQ Capital Market · Currency in USD
$0.15 ▲ +0.00 (+3.08%)
At close: Mar 17, 9:30 AM ET. Market closed.

Summary

Previous Close
$0.15
Open
$0.15
Day's Range
$0.15 – $0.15
52 Week Range
$0.14 – $3.09
Volume
7,897
Avg. Volume
225,203
Market Cap
$3.09M
Beta (5Y Monthly)
0.89
PE Ratio (TTM)
--
EPS (TTM)
-$1.51
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$6.00

Profile: CASI Pharmaceuticals, Inc.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
233
CEO
David A. Cory

CASI Pharmaceuticals, Inc. is a biopharmaceutical firm focused on the development and market introduction of medical treatments and drugs across China, the United States, and globally. Its marketed product, EVOMELA, is an intravenous formulation of melphalan, utilized for conditioning prior to stem cell transplantation and as a palliative option for patients suffering from multiple myeloma. The company's developmental pipeline encompasses several experimental therapies.

Earnings

DateEst.Actual
Nov 14, 2025-$0.40-$0.67Miss
Aug 29, 2025-$0.47-$0.86Miss
May 16, 2025-$0.61-$0.69Miss
Mar 31, 2025-$0.60-$0.79Miss
Nov 15, 2024-$0.62-$0.55Beat
Aug 16, 2024-$0.63-$0.52Beat

Analyst view

Consensus price target
$6.00 ▲ +3,886.7%
Range $6.00 – $6.00
Rating: Buy
Buy 100% · Hold 0% · Sell 0%

Get free alerts on CASI and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.